“As stated by PMI’s Annual Report, the U.S. has partnered with Nigeria to fight malaria since 2011, contributing $768 million dollars to date and $74 million in FY 2021.
COVID-19 vaccine maker BioNTech says it was looking into building malaria and tuberculosis vaccine production sites in Rwanda and Senegal, narrowing its search for African locations and overlooking Nigeria with the highest cases of malaria annually.
Future malaria and tuberculosis vaccines would
```
Members Only
Login or create an account to continue
This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.
New to BusinessDay? Register now and start reading.
```
